4-(1-(1-ethoxyethyl)-1H-pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine
![BK0H67 | 1187595-88-5 | 4-(1-(1-ethoxyethyl)-1H-pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine](https://qncdn.chemcd.cn/alchemypharm/1187595-88-5.png "BK0H67 | 1187595-88-5 | 4-(1-(1-ethoxyethyl)-1H-pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine")
Catalog No.: BK0H67
CAS.RN：1187595-88-5
Molecular Formula: C19H29N5O2Si
Molecular Weight: 387.55 g/mol
Purity: NLT 98%
Intermediates of Baricitinib
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA2K16 | Baricitinib API | 1187594-09-7 |
| BK855Z | 1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | 1029716-44-6 |
| BK0H67 | 4-(1-(1-ethoxyethyl)-1H-pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidine | 1187595-88-5 |
Products are offered for research, development, or industrial use only.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
